跳至主要内容
临床试验/PER-005-04
PER-005-04已完成未知

EFFICACY AND SAFETY OF OLANZAPINE IN PATIENTS WITH BORDELINE PERSONALITY DISORDER: A RANDOMIZED, DOUBLE-BLIND COMPARISON WITH PLACEBO

ELI LILLY INTERAMERICA INC.,0 个研究点目标入组 0 人开始时间: 2004年3月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients must be of outpatient status at Visit 1 and through Visit 2
  • Patients must be 18 through 65 years of age at Visit 1
  • Patients must meet all of the DSM-IV-TR General Diagnostic Criteria for a Personality Disorder AND Patients must meet DSM-IV-TR diagnostic criteria for BPD as determined by the DIPD-IV, confirmed by a psychiatrist with training in the evaluation and assessment of BPD.
  • The symptom severity as assessed by the total score of the ZAN-BPD, confirmed by a psychiatrist with training in the evaluation and assessment of BPD, must be greater than or equal to 9 at Visit 2.
  • Female patients of childbearing potential must test negative for pregnancy and must be using medically accepted means of contraception throughout the study. Use of any oral or injectable contraception must be initiated prior to Visit 2.

排除标准

  • Investigators, study site personnel directly affiliated with the study, or immediate family of investigator site personnel directly affiliated with the study. Immediate family is defined as a spouse, parent, child, or sibling, whether biological or legally adopted.
  • Persons employed by Lilly (that is, employees, temporary contract workers, or designees responsible for the conduct of the study). Immediate family of Lilly employees may participate in Lilly-sponsored clinical trials, but are not permitted to participate at a Lilly facility. Immediate family is defined as a spouse, parent, child, or sibling, whether biological or legally adopted
  • Have previously participated (have been randomized) or withdrawn from this study or any other Lilly sponsored study investigating olanzapine.
  • Have had previous treatment with olanzapine unless, in the opinion of the investigator, the patient´s previous treatment was inadequate in dose or duration to provide an accurate assessment of the therapy, or the effect of olanzapine was confounded by concomitant medication.
  • Female patients who are either pregnant or nursing.

研究者

相似试验

Efficacy and Safety of Olanzapine in Patients With... | 临床试验